United Kingdom · Question · Written question
UIN 148951
Coronavirus: Vaccination
Introduced
3 February 2021
Last action
15 February 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 February 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the validity of the British Medical Association’s reported concerns on the 12-week wait for the second dose of the Pfizer-BioNTech covid-19 vaccine.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 February 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the validity of the British Medical Association’s reported concerns on the 12-week wait for the second dose of the Pfizer-BioNTech covid-19 vaccine.
Source: Commons
15 February 2021
Answer
A phase three clinical trial study on the Pfizer-BioNTech COVID-19 vaccine efficacy demonstrated a two-dose vaccine efficacy of 95% with a second dose delivered between 19 and 42 days.Using data available from this study, Public Health England estimated t...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-02-03/148951
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1283469
- uk · wq-1283469 · source updated 15 February 2021